Zydus Lifesciences Ltd Financials Statements

    Annual and Quarterly P/L, Balance Sheet, Cash Flow & Financial Ratios

    Consolidate
    Standalone
    Financial Year
    Mar '25
    Dec '24
    Sep '24
    Jun '24
    Mar '24
    Total Qtr Revenue cr
    6,608.50
    5,326.60
    5,305.20
    6,270.70
    5,690.20
    Other Income Qtr Cr80.6057.5068.2063.20156.40
    Operating Revenues Qtr6,527.905,269.105,237.006,207.505,533.80

    *All values are in Cr.

    Operating Expenses Qtr
    4,402.40
    3,881.50
    3,775.60
    4,123.50
    3,903.30
    Operating Profit Qtr
    2,125.50
    1,387.60
    1,461.40
    2,084.00
    1,630.50
    EBITDA Qtr Cr
    1,986.50
    1,444.80
    1,529.90
    2,147.20
    1,790.10
    Depreciation Qtr
    237.90
    229.00
    233.60
    215.30
    205.30
    Net Profit Qtr
    1,170.90
    1,026.20
    920.20
    1,482.50
    1,246.10
    Basic EPS Qtr
    11.64
    10.17
    9.06
    14.11
    11.69
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -